Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract research organization (CRO), today announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive ...
read more
Thursday, October 26, 2023
Catawba Research, a clinical research organization announced changes to its executive leadership team. Catawba’s Founder, Zaidoon A. Al-Zubaidy, is transitioning his day-to-day leadership responsibilities to Dr. Andy Silverman. Al-Zubaidy will become...
read more
Wednesday, February 06, 2019
Novasep announced Enzene Biosciences has chosen BioSC Pilot for purification of biopharmaceuticals to operate in its Pune plant.
read more
Thursday, February 11, 2016
Crown Bioscience Inc. has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.
read more
Almac Pharma Services, a member of the Almac Group, has expanded its state-of-the-art Ultra-Low Temperature commercial packaging, labelling and distribution solutions to support the launch of Advanced Therapy Medicinal Products (ATMPs) from its ...
read more
Eurofins Discovery announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues.
read more
Veratrak has announced that CPO Central Pharma has selected its platform to help it achieve digitized end-to-end visibility of its supply chain and improve collaboration.
read more
Wednesday, March 18, 2020
OSE Immunotherapeutics and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor antagonist OSE-127.
read more
Wednesday, October 28, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
read more
Thursday, November 19, 2015
Charles River Laboratories International has acquired Oncotest GmbH, a Freiburg, Germany-based contract research organization (CRO) providing discovery services for oncology, one of the largest therapeutic areas for biopharmaceutical research and ...
read more
Wednesday, January 13, 2016
inVentiv Health, a professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide, today marked the official opening of its new Phase I clinic in the United States, located at the ...
read more
Syneos Health® announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023. Stanford (Ben) Rudnick will continue to serve as Interim Chief Financial Officer until that time.
read more
Mission has raised $15m in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer.
read more
Thursday, January 11, 2018
Charles River has acquired KWS BioTest, a CRO specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases.
read more
Recipharm has achieved the new ISO 45001 certification at its Wasserburg facility in Germany.
read more